
A nonprofit raising research funding to cure #kidneycancer
Alexandria, VA
Joined March 2016
- Tweets1.9K
- Following1.6K
- Followers1.9K
- Likes3K
Honored to participate is this @KidneyCancer led effort bringing stakeholders together to answer a question that is crucial for #kidneycancer pts!
Thank you Axel and Grant for organizing the INKCC moving towards developing a standardized neoadjuvant platform for RCC! @DrChoueiri @deepak_kilari @BradMcG04 @myESMO #ESMO25
4
355
Doctors! Tell us YOUR answer! How should the term “cure” be used in #kidneycancer? #ESMO25 Let’s see how many responses we can get! @DrChoueiri @montypal @DrYukselUrun @TiansterZhang @Uromigos @OncoAlert surveymonkey.com/r/MDCure
#KidneyCancer Patients want cures—but few believe they’re possible. Learn what patients living with metastatic RCC think about the word “cure." 📍Abstract 2636P | #ESMO25 #KidneyCancer #mRCC @TiansterZhang @spsutkaMD @DrVaishampayan @MichaelStaehler @lisapic @AlbigesL
KCCure retweeted
Are you prepared to bring modern #RCC care to your patients across disease stages and histologic subtypes? Get guidance from Drs. Pal (@montypal), McDermott (@uromigos), & Zhang (@tiansterzhang). Produced with @KCCure. bit.ly/4ntmIQ4 #ASCO25 #MedEd
KCCure retweeted
1/5 This comes up in #kidneycancer clinic every few months. And on patient groups just as often.
📊 The ASSURE nomogram shows cumulative disease-free survival (DFS) from time 0 after surgery. Great info… until someone hits the 2-year mark and panics at that 48.8% 3-year number.
KCCure retweeted
🎉 Just 2️⃣ days away!
Join PeerView for 15+ expert-led #CME symposia May 30–31 at #ASCO25!
🍽️ Dinner included
🎓 Free CME
🚌 McCormick shuttles to:
Gate 31 – Hyatt
Gate 26 – Hilton
Gate 21 – Sheraton
🔗 bit.ly/Onc25T
❌ No ASCO reg needed for PeerView events only
@OncBrothers @jhaveri_komal @JavierCortesMD @Ahn_Daniel_Onc @SagarLonialMD @HansLeeMD1
@DrKrinaPatel @Ecastromarcos @JSabari @GlopesMd
@ZPiotrowskaMD @YJanjigianMD @ArndtVogel @HardingJJMD @MacarullaTeresa @NitinJainMD
@MCThompsonMD @KrishPatelMD @HTawbi_MD @TiansterZhang @montypal @CathyEngMD @GhayasIssa @HwakeleeMD @lipika_goyal
@AdamJSchoenfeld @BenCreelan
@JulieBrahmer @Daver_Leukemia @jaltmanmd
📣 Live at #ASCO25: Learn from real-world #RCC cases with @montypal, Dr. McDermott & @TiansterZhang
✅ IO-based regimens
✅ Sequencing therapies
✅ Shared decision-making
🗓️ May 31 | 7:00 PM CDT
🔗 bit.ly/RCC-T
KCCure retweeted
Join Dr. Sumanta Kumar Pal (@montypal) & colleagues on Saturday, May 31, at 6:30 PM CDT/7:30 PM EDT during #ASCO25 for a #RenalCellCarcinoma #MedEd event. Produced with @KCCure. bit.ly/4mdScJu #KidneyCancer #Oncology
KCCure retweeted
His final presentation looking at barriers to genetic counseling in RCC. Congrats @PazLotan on an outstanding job at #AUA2025. @WiscUroOnc @wiscurology @ejasonabel @NakadaSteve
KCCure retweeted
I have been fielding a lot of calls from my #medonc colleagues around availability of #microbiome modulating studies for #kidneycancer at @cityofhope (in particular, #CBM588). The following are the two studies we have enrolling currently (limited slots remaining):
1. NCT06049576: Nivo/Ipi +/- camu camu (PI: @ReginaBarCar)
2. NCT06399419: Nivo/Ipi + CBM588 Dose Escalation/Expansion (PI: @arafflemd)
Investigators, please DM me with questions.
KCCure retweeted
It’s my first #AUAAnnualMeeting - can you believe it?! Thanks @kcCURE for the invite! #AUA2025 #kidneycancer #patientadvocate
KCCure retweeted
I’m honored to serve as the next CEO of the @osuccc_james & look forward to joining my new Buckeye colleagues at @osuwexmed & @ohiostate to take bold steps to advance the future of oncology across Ohio & nationally. Check out my LinkedIn to learn more. go.osu.edu/C4w3
KCCure retweeted
🎉CONGRATULATIONS to @MichaelStaehler, recipient of the KCA's 2025 John Fitzpatrick Award recognizing excellence in urology care! The award will be presented at #IKCSEU25, don't miss his lecture! kidneycancer.swoogo.com/IKCS…
Glad to have this trial speed thru activation @utswcancer ! Enrollment is ongoing!
Excited to announce that the Werewolf Therapeutics trial with WTX-124 has opened @utswcancer. Intriguing way to deliver effective IL-2 without hospitalizations or ICU. Single agent activity. If you have Kidney Cancer, Lung Cancer or Melanoma / Skin cancer then get in touch!
KCCure retweeted
During her husband's five-year fight with kidney cancer, Dena Battle faced constant uncertainty.
The lack of accurate diagnostic tools made treatment decisions challenging, often providing conflicting results and leaving them in doubt.
Today, she is a dedicated patient advocate, working to provide surety to kidney cancer patients. Driven by her heartbreaking experience, she created @kcCURE to empower patients and support research focused on high-impact advancements in cancer care.
During Kidney Cancer Awareness Month, Telix is sitting down with physicians, advocates and patients to shed light on the current unmet needs in kidney cancer.
To learn more about Dena’s work visit: kccure.org/about-us/
U.S. patients and healthcare professionals can learn about how Telix is advancing kidney cancer detection and disease management at SeeccRCC.com
For more on Telix’s portfolio visit: telixpharma.com/kidney
KCCure retweeted
70% of health-related internet searches are zero-click - which means pts are relying on snippets and AI overviews for information. When you see something like this that is outdated, misleading, or both - click on the feedback button. It's a small way you can help improve information for #kidneycancer patients.
KCCure retweeted
I really enjoyed this talk by @TiansterZhang #GU25 @ASCO. RCC is not Jupiter; it is so heterogenous. We try to refine prognostic criteria all the time and hopefully with molecular features or immune status or KIM1 we will succeed. @OncoAlert @DrChoueiri @IMDConline #sciencewins
A great talk by @TiansterZhang in terms of current and future approaches in RCC! @ASCO #GU25
@OncoAlert
@DrYukselUrun @DrChoueiri @NazliDizman @OncLive @DanaFarber_GU @montypal @bavilima @nataliagandur
KCCure retweeted
👀 Eye-opening data from @RCCadvocate & @kcCURE at #GU25:
🔹 44% of #KidneyCancer patients spend hours thinking about cancer 🧠
🔹 36% visited the ER in the last 90 days 🚑
🔹 >1/3 say cancer always/often impacts eating, sleeping & social life 💔
Surviving is not the same as living. We must do better. #Oncology #PatientCare #RCC
#GU35 44% of #kidneycancer pts spend HOURS thinking about cancer. In last 90 days, 36% have gone to ER. >1/3 of patients say that cancer always/often impacts their ability to eat, sleep and engage with family and friends. Surviving is not the same as living. #diseaseburdenzero




































